This was partially because of the limited number of GATA2 outlier cases included in this analysis, but it also indicated that GATA2 activation was a secondary event in B-ALL and would need to cooperate with other driver genomic aberrations in leukemogenesis. The gene discussed is GATA2; the disease is precursor B-cell acute lymphoblastic leukemia.